glp-1 gip dual agonist Schematic illustration of monoagonists, agonists and triple Dual GLP-1 / GIP Receptor
Description
The number needed to treat was 19, meaning that for every 19 patients treated with dapagliflozin, one major kidney event was prevented
Learn all about different types of GLP-1s approved to treat type 2 diabetes and obesity, and how GLP-1/GIP dual agonists and triple agonists compare
10.1016/j.molmet.2020.101102
In mouse studies, administering a GLP-1 analog has been shown to reduce alcohol and cocaine use
Song, J
Samms RJ, Coghlan MP, Sloop KW, Samms RJ, Coghlan MP, Sloop KW
